Portfolio company
Starna Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops messenger RNA medicines and extrahepatic delivery systems for pharmaceutical firms and clinical researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Etherna
This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.
Argonaute RNA
This biotechnology firm develops bispecific siRNA therapeutics for cardiometabolic diseases, serving pharmaceutical partners and research institutions engaged in advanced therapeutic research.
Sensible Biotechnologies
This company develops a cell-based platform to produce mRNA for pharmaceutical firms and biotechnology researchers developing therapeutics and vaccines.
Xterna
The company develops enhanced nucleic acids to provide targeted drug delivery solutions for pharmaceutical and biotechnology researchers seeking to treat previously inaccessible diseased tissues.
Averna Therapeutics
This biotechnology company develops genomic medicines using RNA-based technology to insert therapeutic genes into safe genomic locations for patients with various diseases.
Breeze
This company develops polymer nanoparticles to enable the non-viral delivery of RNA therapeutics to extrahepatic tissues for biotechnology and pharmaceutical organisations.
Nuntius Therapeutics
This company develops mRNA and gene-editing therapies using a programmable nanocarrier delivery platform for pharmaceutical companies and research institutions.
ST Pharm
This company manufactures active pharmaceutical ingredients, oligonucleotides and messenger RNA for global pharmaceutical and biotechnology organisations.
